Dr. MacDonald is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
One Veterans Dr
Minneapolis, MN 55455
Summary
- Dr. David MacDonald is a pulmonologist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including University of Minnesota and Minneapolis Veterans Affairs Health Care System. He received his medical degree from University of Minnesota Medical School and has been in practice 4 years. He specializes in asthma & copd and critical care medicine and is experienced in chronic obstructive pulmonary disease. He has more than 10 publications and over 50 citings.
Education & Training
- University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 2018 - 2021
- University of MinnesotaChief Residency, Internal Medicine, 2017 - 2018
- University of MinnesotaResidency, Internal Medicine/Pediatrics, 2013 - 2017
- University of Minnesota Medical SchoolClass of 2013
Certifications & Licensure
- MN State Medical License 2017 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 14 citationsAssociations between baseline biomarkers and lung function in HIV-positive individuals.David M MacDonald, Alexander D Zanotto, Gary Collins, Jason V. Baker, Marcin Czarnecki
AIDS. 2019-03-15 - 13 citationsSmoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary Substudy.David M MacDonald, Anne C. Melzer, Gary Collins, Anchalee Avihingsanon, Kristina Crothers
Journal of Acquired Immune Deficiency Syndromes. 2018-11-01 - 2 citationsLung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial.Trisha M Parekh, Erika S Helgeson, John Connett, Helen Voelker, Sharon X Ling
Annals of the American Thoracic Society. 2022-10-01
Press Mentions
- Chronic Obstructive Pulmonary Diseases: Journal of the COPD FoundationJune 11th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: